Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Pharmacology|January 1, 1983
Influence of different forms of tobacco intake on nicotine elimination in manG A Kyerematen, B H Dvorchik, E S VesellClinical Pharmacology and Therapeutics|March 1, 1978
Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthinesD D Drouillard, E S Vesell, B H DvorchikProceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twinsM B Penno, B H Dvorchik, E S VesellFertility and Sterility|September 1, 1976
Antenatal sex determination in Macaca arctoidesM Daniels, H C Hughes, M Lang, et al.Journal of Clinical Pharmacology|March 1, 1988
Pregnancy-specific changes of antipyrine pharmacokinetics correlate inversely with changes of estradiol/progesterone plasma concentration ratiosW Loock, H Nau, M Schmidt-Gollwitzer, et al.Developmental Pharmacology and Therapeutics|January 1, 1986
Hydroxylation and glucuronidation of various xenobiotics by hepatic microsomes from the fetal lamb, pregnant ewe and human fetusB H Dvorchik, G Woodward, D S Sitar, et al.Clinical Pharmacology and Therapeutics|December 1, 1982
Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolitesG A Kyerematen, M D Damiano, B H Dvorchik, et al.Clinical Pharmacology and Therapeutics|October 1, 1983
Theobromine kinetics and metabolic dispositionS M Tarka, M J Arnaud, B H Dvorchik, et al.Clinical Pharmacology and Therapeutics|September 1, 1975
Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineE S Vesell, G T Passananti, P A Glenwright, et al.Journal of Clinical Pharmacology|July 1, 1985
Plasma protein binding of bepridilJ F Pritchard, L A McKown, B H Dvorchik, et al.Pageof 3